Literature DB >> 26437036

Generalized Anxiety Disorder and Pain.

Borwin Bandelow1.   

Abstract

In this article, the co-occurrence of anxiety disorders (in particular generalized anxiety disorder) and pain conditions is described, characteristics of chronic pain are explained, and data on the prevalence of co-comorbidity of both conditions are reviewed. Further, hypotheses on the possible psychosocial and neurobiological backgrounds of the high rate of co-occurrence are discussed. This review will also focus on the role of 'unexplained' pain syndromes (e.g. somatic symptom disorder and fibromyalgia) and anxiety. Finally, we address possible treatment strategies for patients with both conditions. There is a need for a rigorous assessment of pain syndromes in generalized anxiety disorder and anxiety in chronic pain conditions in order to prevent subsequent mortality by early treatment of both conditions.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26437036     DOI: 10.1159/000435939

Source DB:  PubMed          Journal:  Mod Trends Pharmacopsychiatry        ISSN: 0077-0094


  6 in total

1.  Further evaluation of the potential anxiolytic activity of imidazo[1,5-a][1,4]diazepin agents selective for α2/3-containing GABAA receptors.

Authors:  J M Witkin; R Cerne; M Wakulchik; J S; S D Gleason; T M Jones; G Li; L A Arnold; J-X Li; J M Schkeryantz; K R Methuku; J M Cook; M M Poe
Journal:  Pharmacol Biochem Behav       Date:  2017-04-22       Impact factor: 3.533

2.  The α2,3-selective potentiator of GABAA receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats.

Authors:  J M Witkin; R Cerne; P G Davis; K B Freeman; J M do Carmo; J K Rowlett; K R Methuku; A Okun; S D Gleason; X Li; M J Krambis; M Poe; G Li; J M Schkeryantz; R Jahan; L Yang; W Guo; L K Golani; W H Anderson; J T Catlow; T M Jones; F Porreca; J L Smith; K L Knopp; J M Cook
Journal:  Pharmacol Biochem Behav       Date:  2019-02-27       Impact factor: 3.533

Review 3.  Chronic Pain and the Endocannabinoid System: Smart Lipids - A Novel Therapeutic Option?

Authors:  Walter Zieglgänsberger; Rudolf Brenneisen; Achim Berthele; Carsten T Wotjak; Borwin Bandelow; Thomas R Tölle; Beat Lutz
Journal:  Med Cannabis Cannabinoids       Date:  2022-03-22

Review 4.  Delineating conditions and subtypes in chronic pain using neuroimaging.

Authors:  Scott A Holmes; Jaymin Upadhyay; David Borsook
Journal:  Pain Rep       Date:  2019-08-07

Review 5.  Current Understanding of the Neural Circuitry in the Comorbidity of Chronic Pain and Anxiety.

Authors:  Teng Chen; Jing Wang; Yan-Qing Wang; Yu-Xia Chu
Journal:  Neural Plast       Date:  2022-02-15       Impact factor: 3.599

6.  Sex Differences in Comorbidity Combinations in the Swedish Population.

Authors:  Laura Basso; Benjamin Boecking; Patrick Neff; Petra Brueggemann; Christopher R Cederroth; Matthias Rose; Birgit Mazurek
Journal:  Biomolecules       Date:  2022-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.